• SENSEX 73,709.69
    -143.21 (--0.19%)
  • BANKNIFTY 54,976.90
    -511.20 (--0.92%)
  • Max Healthcare
    811.50 811.50(%)
  • L&T Technology
    4,140.50 4,746.95(%)
  • Bajaj Finance
    919.00 788.40(%)
  • NSE
    1,705.00 1,705.00(%)
  • Reliance Industries
    1,234.60 1,611.20(%)
  • TCS
    2,533.10 3,336.70(%)
  • PC Jeweller
    19.14 19.14(%)
  • Cupid
    343.65 369.70(%)
  • HD Fire Protect
    338.00 338.00(%)
  • Infosys
    1,171.00 1,727.85(%)
  • ZF Commercial
    2,073.00 2,053.38(%)
  • Aditya Infotech
    3,879.70 1,301.10(%)
  • HDFC Bank
    698.35 682.00(%)
  • Fractal Analyt.
    828.00 1,119.60(%)
  • SS Retail
    724.90 888.00(%)
  • ICICI Bank
    1,409.50 1,479.90(%)
  • APL Apollo Tubes
    2,052.10 1,691.05(%)
  • Sun Pharma.Inds.
    1,721.70 1,583.60(%)
  • Netweb Technol.
    4,575.95 2,942.45(%)
  • CreditAcc. Gram.
    1,129.35 1,112.90(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Trident Lifeline Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 77345.0
  • ISIN : INE0MKA01014
387.95 -14 (-3.50%)
  • As on 21 Oct 2026 (EOD)

  • Today’s Low

    382.50

  • Today’s High

    425.00

  • Open

    425.00

  • Perv Close

    402.00

  • 52W Low

    229.95

  • 52W High

    425.00

Key Indicators

  • P/E(TTM)

    23.67

  • Mar.Cap (₹Cr.)

    464.80

  • Div & Yield %

    0.00

  • Book Value(₹)

    80.66

  • Debt-Equity Ratio

    -3.50

  • AGM Date

    21-Oct-2026

  • EPS

    16.39

  • P/E Ratio

    23.67

Financials Ratios

  • Debt-Equity Ratio

    0.26

  • Mar.Cap (₹Cr.)

    464.80

  • RONW (%)

    12.06

  • ROCE (%)

    14.99

Score Board

  • Equity (₹ in Cr.)

    11.98

  • BV (₹)

    80.70

  • Sales( ₹ in Cr.)

    101.90

  • NP (in Cr.)

    18.10

  • NP Var(%)

    39.0

  • Div%

    0.0

  • CPS (₹)

    16.70

  • EPS (₹)

    15.10

  • Traded Value (₹ in Lakhs)

    464.80

  • 52 Week High

    425.00

  • 52 Week Low

    229.95

  • Price BSE

    388.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    464.80

  • P/C Ratio

    23.30

  • P/E Ratio

    25.70

  • Price Vs.BV

    15.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 101.90 67.80 44.65 31.69 21.77 9.62
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 101.90 67.80 44.65 31.69 21.77 9.62
Other Income 4.17 3.14 2.20 1.15 0.60 0.16
Stock Adjustments 1.95 -1.47 0.67 2.89 0.46 0.41
Total Income 108.02 69.47 47.52 35.73 22.83 10.19
EXPENDITURE :            
Raw Materials 64.23 34.74 30.23 23.12 14.69 5.92
Power and Fuel Cost 0.23 0.14 0.07 0.03 0.02 0.02
Employee Cost 2.94 2.51 1.55 1.39 1.10 0.70
Other Manufacturing Expenses 7.99 8.73 2.54 2.38 2.66 1.29
Selling and Administration Expenses 2.92 1.76 1.36 0.98 0.94 0.83
Miscellaneous Expenses 1.19 0.79 0.70 0.42 0.11 0.01
Employee Benefit Expenses 2.94 2.51 1.55 1.39 1.10 0.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 79.50 48.66 36.45 28.33 19.52 8.78
Operating Profit 28.52 20.81 11.08 7.42 3.32 1.41
Interest 1.68 1.38 0.51 0.48 0.13 0.41
Gross Profit 26.84 19.43 10.57 6.94 3.19 1.00
Depreciation 1.86 1.53 0.77 0.36 0.20 0.14
Profit Before Tax 24.98 17.90 9.80 6.58 2.99 0.86
Current Tax 6.40 4.25 2.38 0.04 -0.14 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.49 0.60 0.37 0.52 -0.82 0.22
Reported Net Profit 18.09 13.05 7.04 6.01 3.95 0.63
Extraordinary Items -0.01 0.00 0.01 0.00 0.00 0.00
Adjusted Net Profit 18.10 13.05 7.03 6.01 3.95 0.63
Adjustment below Net Profit 0.00 0.00 0.00 -0.50 0.00 -0.63
P & L Balance brought forward 22.38 9.33 2.29 -3.22 -7.17 -6.10
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 -0.63
P & L Balance carried down 40.48 22.38 9.33 2.29 -3.22 -5.47
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 15.16 11.35 6.13 5.23 4.93 1.26
Earnings Per Share(Adj)-Unit Curr 15.16 11.35 6.13 5.23 - -
Book Value 79.91 57.16 45.81 39.68 5.97 -0.94
Book Value(Adj)-Unit Curr 79.91 57.16 45.81 39.68 - -

Shareholding Pattern

  • Promoter Group

    62.46%

  • Public Share Holding

    37.54%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 65,200 65,200.00 65,200 65,200
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 65,200 0.55 65,200 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 109,300 0.91 109,300 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 6,436,534 53.83 6,436,534 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 857,366 7.17 857,366 1
Others 0 0.00 0 0
Sub Total 7,403,200 61.92 7,403,200 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 138,600 1.16 138,600 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 25,200 0.21 25,200 2
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 163,800 1.37 163,800 5
2] Non Institution
Bodies Corporate 718,200 6.01 718,200 22
Clearing Members 45,600 0.38 45,600 4
Directors of their Relatives 90,600 0.76 90,600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 22,200 0.19 22,200 15
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 436,800 3.65 436,800 85
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,141,800 9.55 1,141,800 28
Individuals holding nominal share capital up to Rs. 1 lakh 1,815,000 15.18 1,815,000 880
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 54,600 0.46 54,600 1
Sub Total 4,324,800 36.17 4,324,800 1,036
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 11,957,000 100.00 11,957,000 1,053

Company Background

Trident Lifeline LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Trident Lifeline Ltd
  • BSE Code : 77345.0
  • ISIN : INE0MKA01014

  • Incorporation Year

    2014

  • Registered Office

    2nd Floor Shop 2004 North Ext.
    Falsawadi Begumpura Nodh4/1650, Surat,
    Gujarat-395003

  • Telephone

    91-0261-2490224/8160276395

  • FAX

  • Chairman

    Hardik J Desai

  • Managing Director

    Shravan Harikrishna Patel

  • Company Secretary

    Nikita Sharma

  • Auditor

    A Bafna & Associates.

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Trident Lifeline Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Trident Lifeline 387.95 106.07 101.90 23.67 26.08
Abbott India 25,744.40 7,217.19 6,929.05 33.88 43.78
Astrazeneca Phar 6,076.90 2,304.07 2,275.58 89.56 27.86
Glaxosmi. Pharma 2,463.75 3,932.76 3,790.20 39.36 58.17
Novartis India 1,768.90 393.10 354.33 44.67 15.94
Cipla 1,313.80 20,102.60 18,979.95 34.53 13.88
Bliss GVS Pharma 609.80 773.53 729.81 56.67 12.51
Amrutanjan Healt 495.10 520.13 502.55 26.52 24.16
Fermenta Biotec. 465.60 474.15 450.25 21.74 18.77
Guj. Themis Bio. 351.30 168.25 165.82 93.93 18.05
Ambalal Sarabhai 36.94 19.52 3.94 68.41 6.77